A Bright Light for Postpartum Depression

NYC Psychiatry is now offering ZULRESSO™ (brexanolone) for postpartum depression (PPD). It is the only medication approved specifically to treat postpartum depression. The treatment consists of a 60 hour infusion delivered in a comfortable, home-like setting. Here in New York, where mom’s have been delivering in such isolated settings 2/2 COVID they’re placed at increased risk […] Read more…

Let’s Honor Mothers During the Pandemic

As May 2020 is coming to a close, let’s not forget Maternal Mental Health and women who are trying to conceive or suffering from PMADS. It’s an awareness that should stay with us all-year-round. May 2020 proved to be an unduly difficult time for many new Mom’s who are encountering decreased support resources, frightening restrictions, […] Read more…

NYC Psychiatry & Coronavirus Disease (COVID-19)

A Compassionate Word to Our Patients during this Unprecedented Time With each passing day, New York City feels more and more like the epicenter of the coronavirus disease (COVID-19) pandemic. The well-being of our patients is at the forefront of our thoughts in the face of this new threat. Mental healthcare must be accessible, now […] Read more…

Boutique Psychiatry Centers in NYC are Disrupting Traditional Psychiatry with Advanced Treatments for Depression

Boutique psychiatric practices are growing in popularity as patients start to recognize the freedom small private practices have to offer treatments that are truly the best fit for the patient. Large medical centers are sometimes geared towards, research, training and addressing the needs of large patient populations, but small practices with a focused, patient-centered approach […] Read more…

Brainsway dTMS Continues to Impress as Depression Treatment Heading into 2020

Deep TMS or ‘dTMS’, a form of transcranial magnetic stimulation that addresses deeper lying brain pathways than its sister treatment rTMS, is continuing to impress practitioners and their patients heading into 2020. BrainsWay dTMS is a non-invasive treatment that safely and effectively targets regions of the brain to combat the effects of major depressive disorder […] Read more…

How To Handle Emotional Triggers This Holiday Season

It’s that time of year again!             You know, the time of year when our culture, the media, and almost every holiday song insists that it’s  ‘the most wonderful time of the year’? But for many it’s not.             The holidays can be especially difficult for those suffering from a mental illness. Feelings of loneliness, […] Read more…

Combining TMS with Psychotherapy for Treating Depression and OCD

Transcranial Magnetic Stimulation (TMS), a safe, non-invasive type of brain stimulation, was approved by the FDA for the treatment of depression in 2008, and is now clinically available for the treatment of adults who have not been helped by antidepressant medications. Recently, FDA cleared TMS for use in patients with obsessive-compulsive disorder, if given immediately […] Read more…

Neuromodulation for treatment-resistant depression

Abstract Treatment-resistant depression affects at least 1-3% of the US population. This article reviews the current state of focal neuromodulation therapies for treatment-resistant depression, focusing on those treatments published clinical data. These include transcranial magnetic stimulation, transcranial direct current stimulation, magnetic seizure therapy, vagus nerve stimulation, direct cortical stimulation, and deep brain stimulation among others. […] Read more…

The expanding evidence base for rTMS treatment of depression

Mark S. George, Joseph J. Taylor, and E. Baron Shor INTRODUCTION Transcranial magnetic stimulation (TMS) is perhaps the most popular of the new brain stimulation techniques because its clinical effects are produced without the need for a craniotomy [as with deep brain stimulation (DBS)] or seizure induction [as with electroconvulsive therapy (ECT)]. As a focal, […] Read more…

1 2 3 18